Citius Oncology, Inc
Price
FilingsNewest: 8-K, Shareholder voteSep 29 →InsidersNo open-market buys or sales.→HoldersArmistice Capital 8.2%Bank OF America Corp /de/ 3.6%Vanguard 0.5%→Financing →
From the filings
Figures
- Net income
- −$46.1Mlast 12 months
- Operating cash flow
- −$5.5Mlast 12 months
- Cash and equivalents
- $16.6Mat the last balance sheet
- Shares outstanding
- 105.8M shareson issue